NEW YORK (360Dx) – PTS Diagnostics announced today the US Food and Drug Administration cleared the company's medical device convenience kit for quantitatively measuring the percent of glycated hemoglobin, total cholesterol, high-density lipoprotein, triglycerides, and glucose in whole blood.
The Indianapolis-based firm said that the kits will be the product aspect for its PreVantage suite of products, strategies, and partnerships for healthcare organizations.
PTS Diagnostics previously received FDA clearance that expanded the top of the range for measurement of HDL cholesterol on PTS Panels, its point-of-care lipid panel test strips.